Anti-platelet drugs are necessary in treating patients with coronary artery disease, ischemic stroke and peripheral arterial disease. However, despite the use of adequate anti-platelet therapy, some patients will experience a recurrent atherothrombotic vascular event. These patients are characterized as low- or non-responders to therapy. Individual responsiveness to anti-platelet therapy as the use of clopidogrel and/or aspirin varies widely among patients. Such an individual variability is mainly determined by environmental and genetic factors. In this review, we focused on the underlying genetic mechanisms that might influence response to anti-platelet drugs.
http://ift.tt/2cgMAfH
http://ift.tt/2bYH5QB
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase ...
-
Abstract Paraquat (PQ) intoxication seriously endangers human beings' health, however, the underlying mechanisms are still unclear. He...
-
Abstract Forest fire is a natural disturbance that occurs in many terrestrial ecosystems specifically in the semi-arid environments and is ...
-
Abstract Purpose To clarify the profile of adverse events from endocrine therapies in older patients. Methods We surveyed 15 subject...
-
Objectives No large population-based studies have reported on the risk of cholesteatoma developing after allergic rhinitis (AR). This stu...
-
Prevalence, surgical outcomes and considerations : Introduction Lentigo maligna (LM) is melanoma in situ on sun-damaged skin and presen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου